Form D · Other Health Care

BioTrace Medical, Inc.

Menlo Park, CA · CIK 0001600446

Offering snapshot reported Mar 16, 2021 · SEC filing

Reported sold
$10.9M
Offering amount: $16.3M
Investors reported
19
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 1, 2021
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 16, 2021Initial$10,865,393No comparison19SEC filing
May 15, 2017Initial$5,681,262No comparison9SEC filing
Jul 24, 2015Initial$1,702,638No comparison6SEC filing
Feb 25, 2014Initial$3,491,067No comparison6SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-392374

Source: Form D, filed Mar 16, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Robert Brownell Director
Laura N, Dietch Director, Executive
Thomas Fogarty, Md Director
Adam Henick Director
Drew Hoffmann Director
Ronald Mizrahi Director
Shilen Patel Director
Kurt Sparks Executive
Sharon Stevenson Director
Sharon Stevenson, Dvm, Ph D Director
Aravind Swaminathan Director, Executive
Aravind Swaminathan, Md Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
3925 Bohannon Drive Suite 200
Menlo Park, CA, 94025